9Boersma E, Harrington RA, Moliterno DJ, et al. platelet glycoprotein iib/iiia inhibitors in acute coronary major randomised clinical trials[J] 198 syndromes : a meta - analysis of all Lancet, 2002, 359(9302):189-.
10James S, Akerblom A,Cannon CP,et al. comparison of ticagrelor, the first reversible oral p2y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: rationale, design, and baseline characteristics of the platelet inhibition and patient outcomes (plato) trial[ J]. Am Heart J, 2009, 157 (4) :599 - 605.
